Neurovascular Devices Market Report, Forecast 2022-2027: Industry Size, Trends, Share and Growth

The latest research study “Neurovascular Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global neurovascular devices market size reached US$ 2.56 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 3.7 Billion by 2027 exhibiting a growth rate (CAGR) of 6.12% during 2022-2027.

Get Report with TOC & List of Figure:

Neurovascular devices are specialized equipment that are used for treating neurological disorders, such as brain aneurysms, atherosclerosis, Dural arteriovenous fistula, etc. They can be categorized into coils, stents, clips, etc. These neurovascular devices prove highly effective in diagnosing and treating multiple types of peripheral and central nervous system ailments. They aid in preventing blood clots and reduce the risk of strokes. Consequently, neurovascular devices find extensive applications across numerous segments of the healthcare sector, including hospitals, ambulatory surgery centers, neurology clinics, etc.

Covid-19 Impact :

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Neurovascular Devices Market Trends and Drivers: 

The expanding geriatric population and the increasing prevalence of several neurological diseases across the globe are primarily driving the neurovascular devices market. Besides this, the launch of various favorable policies by government bodies, especially in developing countries, aimed at modernizing the medical infrastructure is acting as another significant growth-inducing factor.

Additionally, the shifting preferences toward minimally invasive surgeries (MIS), owing to multiple benefits that include less postoperative pain, faster recovery time, shortened hospital stay, smaller incision, less scarring, and reduced stress on the immune system, are also positively influencing the global market. Moreover, the rising demand for embolization coils and occlusion devices to treat arteriovenous malformation (AVM) and the inflating investments undertaken by the leading market players in research and development (R&D) activities to ensure technological advancements in neurological devices are further catalyzing the market growth.

 Apart from this, the growing number of exclusive hospitals that strive to provide comprehensive treatment options related to brain and spine disorders are expected to propel the neurovascular devices market over the forecasted period

Request a PDF Sample Copy for more detailed market insights:

Report Segmentation:

The report has been segmented the market into following categories:

Breakup by Product:

  • Cerebral Embolization and Aneurysm Coiling Devices
    • Embolic Coils
    • Flow Diverters
    • Liquid Embolic Agents
  • Cerebral Angioplasty and Stenting Systems
    • Carotid Artery Stents
    • Embolic Protection Devices
  • Neurothrombectomy Devices
    • Clot Retrieval Devices
    • Suction Devices
    • Vascular Snares
  • Support Devices
    • Micro Catheters
    • Micro Guidewires  

Breakup by Application:

  • Ischemic Stroke
  • Aneurysm
  • Arteriovenous Malformation and Fistulas (AVM)
  • Stenosis
  • Others  

Breakup by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Others

By Geography:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

List of Major Key Players:

The major players in the market are 

  • Acandis GmbH
  • Asahi Intecc Co. Ltd. (TYO: 7747) 
  • Imperative Care Inc.
  • Integer Holdings Corporation
  • Johnson & Johnson (NYSE: JNJ)
  • Medtronic plc
  • MicroPort Scientific Corporation (HKG: 0853)
  • Penumbra Inc.
  • Perflow Medical Ltd.
  •  Rapid Medical
  •  Stryker Corporation (NYSE: SYK)
  • Terumo Corporation

Key highlights of the report:

  • Market Performance (2016-2021)
  • Market Outlook (2022- 2027)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

By Master James

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts